IPO registrations (S-1, F-1) · Registrants

ANTARES PHARMA, INC.

SEC CIK
1016169 · filings on EDGAR ↗
Name on the registration
MEDI JECT CORP /MN/
Former names
ANTARES PHARMA INC (2005–2008); ANTARES PHARMA INC (2002–2006); ANTARES PHARMA INC /MN/ (2001–2002); MEDI JECT CORP /MN/ (1996–2001)
Registration
Form S-1, first filed 1996-06-24, last 1996-10-01; 1 initial registration, 4 amendments
Outcome
Final prospectus filed 1996-10-03
Industry (SIC)
Surgical & Medical Instruments & Apparatus 3841
Incorporated in
DE
Business address
100 PRINCETON SOUTH, SUITE 300, Ewing, NJ 08628
EIN
41-1350192
EDGAR entity type
operating
Insiders and CEO pay
ANTARES PHARMA, INC. on the corporate pages

Offering terms

Proposed price range
$5.50–$6.00 per share (S-1/A filed 1996-10-01)
Final price
$4.60 per share, below the range (424B1 filed 1996-10-03, an initial public offering)
Shares sold
2,200,000
Gross proceeds
$10,120,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol MEDJ
Lead underwriters
Rodman & Renshaw; R. J. Steichen & Company (320,000 shares)
Syndicate
Adams Harkness (50,000); Advest, Inc (50,000); Cruttenden Roth Incorporated (50,000); Fahnestock & Co. Inc (50,000); Gerard Klauer Mattison & Co., LLC (50,000); Hanifen, Imhoff Inc (50,000); Janney Montgomery Scott (50,000); Jefferies (50,000); Ladenburg Thalmann (50,000); Needham & Company (50,000); Pennsylvania Merchant Group Ltd (50,000); Punk, Ziegel & Knoell (50,000); Roney & Co (50,000); Sutro & Co. Incorporated (50,000); Tucker Anthony Incorporated (50,000); Van Kasper & Company (50,000); Frederick & Company, Inc (30,000); Genesis Merchant Group Securities (30,000); John G. Kinnard & Company, Incorporated (30,000); Nordberg Capital Inc (30,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 6

FiledFormWhat it isName as filedEDGAR
1996-06-24S-1S-1 (registration)MEDI JECT CORP /MN/0000950109-96-003997 ↗
1996-08-15S-1/AS-1/A (amendment)MEDI JECT CORP /MN/0000950130-96-003240 ↗
1996-09-24S-1/AS-1/A (amendment)MEDI JECT CORP /MN/0000950131-96-004701 ↗
1996-09-27S-1/AS-1/A (amendment)MEDI JECT CORP /MN/0000950131-96-004791 ↗
1996-10-01S-1/AS-1/A (amendment)MEDI JECT CORP /MN/0000950131-96-004836 ↗
1996-10-03424B1424B1 (final prospectus)MEDI JECT CORP /MN/0000950131-96-004872 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
1996-10-01S-1/Aregistration statement$5.50–$6.002,750,000-Nasdaq MEDJ1from the submission text; range, shares headline, cover names 1document ↗
1996-10-03424B1final prospectus$4.602,200,000$10,120,000Nasdaq MEDJ22from the submission text; price line, shares headline, proceeds computed, underwriting table 21, cover names 1document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
GARRITY THOMAS JDirector352006–2022
GONELLA JACQUESDirector; Director,TenPercentOwner432006–2019
GUETH ANTONDirector332006–2022
SHROTRIYA RAJESH CDirector102006–2012
Wotton Paul KDirector; Director,OfficerPresident and CEO; President and COO342006–2014
CARRARA DARIOOfficerManaging Director-Formulations; Senior Vice President; Senior Vice President (1)72006–2010
HATTERSLEY JAMES EOfficerVice President-Business Develo12006
SADOWSKI PETER LOfficer; OtherSenior Vice President; Vice President; VP-Device Group142006–2012
STOVER JACK EDirector,Officer; OfficerCEO; President and CEO; President/CEO62006–2008
APPLE ROBERT FDirector,Officer; OfficerExecutive Vice President & CFO; Executive Vice President & COO; President and CEO; President & CEO; Senior Vice President and CFO; Senior VP and CFO; Sr VP and CFO612006–2022
JACOB LEONARD SDirector462007–2022
HOBBS EAMONN PDirector; Director,OfficerPresident and CEO; President & CEO172009–2015person page Fuzzy
DAVE KAUSHIK JOfficerExecutive Vice President82011–2013
SAMSON MARVINDirector152013–2020
ROCHE ROBERT P JRDirector152013–2022person page Fuzzy
Stacey Jennifer EvansOfficerSVP, General Counsel & Secty42014–2015person page Fuzzy
Fickenscher James EOfficerSenior Vice President & CFO72014–2016
Deerfield International Master Fund, L.P.TenPercentOwnerOther112015
DEERFIELD MANAGEMENT COTenPercentOwnerOther112015
Deerfield Mgmt L.P.TenPercentOwnerOther112015
DEERFIELD PARTNERS, LPTenPercentOwnerOther112015
Deerfield Special Situations Fund, L.P.TenPercentOwnerOther82015
Flynn James ETenPercentOwnerOther112015person page Fuzzy
GRAHAM PETER JOfficerEVP General Counsel, Secretary; See Remarks; SVP General Counsel, Secretary222015–2022
Muckenhirn Keith EOfficerVP/Controller & Interim CFO12016
Powell Fred MOfficerExecutive Vice President & CFO; Senior Vice President & CFO192016–2022
Tursi James PatrickOfficerEVP, Chief Medical Officer32018–2019
Greenleaf PeterDirector62018–2022
Smith Karen L.Director62019–2022
Richardson Peter COfficerEVP, R&D Chief Medical Officer; See Remarks42021–2022
Volkart Carmen BDirector32021–2022

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationAntares Pharma, Inc.NJState business registriesname and state
Business registrationAntares Pharma, Inc.NJState business registriesname and state
Business registrationAntares Pharma, Inc.NJState business registriesname and state
Business registrationANTARES PHARMA, INC.NJState business registriesname and state
Business registrationANTARES PHARMA, INC.NJState business registriesname and state
Business registrationANTARES PHARMA, INC.NJState business registriesname and state
Business registrationANTARES PHARMA, INC.NJState business registriesname and state
Business registrationANTARES PHARMA, INC.NJState business registriesname and state
Plan sponsorANTARES PHARMA, INC.NJForm 5500 (employee benefit plans)name and state
Federal award recipientANTARES PHARMA INCNJFederal spending (USAspending)name and state
Lobbying clientANTARES PHARMANJFederal lobbying (LDA)name and state
Lobbying clientANTARES PHARMA, INC.NJFederal lobbying (LDA)name and state
Paying companyAntares Pharma, Inc.NJOpen Payments (drug and device company payments)name and state
Patent assigneeAntares Pharma, Inc.NJPatents (USPTO)name and state
SEC filerANTARES PHARMA, INC.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerAntares Pharma Inc.NJTrademarks (USPTO)name and state
Form 5500 plan sponsorANTARES PHARMA, INC.EIN (EXACT)
Person pageEamonn P HobbsPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer)
Person pageJames E FlynnPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther)
Person pageJennifer Evans StaceyPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer)
Person pageRobert P Roche JrPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Surgical & Medical Instruments & Apparatus, NJ first:

More with this interest.

In other datasets, the same topic (Technology) in NJ:

Interests: Surgical & Medical Instruments & Apparatus · Technology